The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 728K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

11 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery and characterization of novel selective inhibitors of carbonic anhydrase IX.EBI
Vilnius University
Design of [(2-pyrimidinylthio)acetyl]benzenesulfonamides as inhibitors of human carbonic anhydrases.EBI
Vilnius University
4-[N-(substituted 4-pyrimidinyl)amino]benzenesulfonamides as inhibitors of carbonic anhydrase isozymes I, II, VII, and XIII.EBI
Vilnius University
Comprehensive analysis of resorcinyl-imidazole Hsp90 inhibitor design.EBI
Vilnius University
Halogenated and di-substituted benzenesulfonamides as selective inhibitors of carbonic anhydrase isoforms.EBI
Vilnius University
Benzenesulfonamides with pyrimidine moiety as inhibitors of human carbonic anhydrases I, II, VI, VII, XII, and XIII.EBI
Vilnius University
Antiproliferative activity of novel benzo[b][1,6]naphthyridines in human solid tumor cell lines.EBI
Vilnius University
Benzimidazole design, synthesis, and docking to build selective carbonic anhydrase VA inhibitors.EBI
Vilnius University
Design of two-tail compounds with rotationally fixed benzenesulfonamide ring as inhibitors of carbonic anhydrases.EBI
Vilnius University
Introduction of Intrinsic Kinetics of Protein-Ligand Interactions and Their Implications for Drug Design.EBI
Vilnius University
Benzofurane compoundsBDB
Hoffmann-La Roche